BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9646325)

  • 1. Developmental expression of cytochrome P450 enzymes in human liver.
    Hakkola J; Tanaka E; Pelkonen O
    Pharmacol Toxicol; 1998 May; 82(5):209-17. PubMed ID: 9646325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 3A: ontogeny and drug disposition.
    de Wildt SN; Kearns GL; Leeder JS; van den Anker JN
    Clin Pharmacokinet; 1999 Dec; 37(6):485-505. PubMed ID: 10628899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth.
    Lacroix D; Sonnier M; Moncion A; Cheron G; Cresteil T
    Eur J Biochem; 1997 Jul; 247(2):625-34. PubMed ID: 9266706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers.
    Hakkola J; Raunio H; Purkunen R; Saarikoski S; Vähäkangas K; Pelkonen O; Edwards RJ; Boobis AR; Pasanen M
    Biol Neonate; 2001; 80(3):193-201. PubMed ID: 11585982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of developmental aspects of cytochrome P450.
    Oesterheld JR
    J Child Adolesc Psychopharmacol; 1998; 8(3):161-74. PubMed ID: 9853690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation.
    Li Y; Cui Y; Hart SN; Klaassen CD; Zhong XB
    Mol Pharmacol; 2009 May; 75(5):1171-9. PubMed ID: 19188337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 genetic polymorphism in neonatal drug metabolism: role and practical consequences towards a new drug culture in neonatology.
    Fanni D; Ambu R; Gerosa C; Nemolato S; Castagnola M; Van Eyken P; Faa G; Fanos V
    Int J Immunopathol Pharmacol; 2014; 27(1):5-13. PubMed ID: 24674673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 Pig liver pie: determination of individual cytochrome P450 isoform contents in microsomes from two pig livers using liquid chromatography in conjunction with mass spectrometry [corrected].
    Achour B; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2011 Nov; 39(11):2130-4. PubMed ID: 21795467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onset of xenobiotic metabolism in children: toxicological implications.
    Cresteil T
    Food Addit Contam; 1998; 15 Suppl():45-51. PubMed ID: 9602911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
    Karam WG; Goldstein JA; Lasker JM; Ghanayem BI
    Drug Metab Dispos; 1996 Oct; 24(10):1081-7. PubMed ID: 8894508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors.
    Betts S; Björkhem-Bergman L; Rane A; Ekström L
    Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):261-6. PubMed ID: 25689036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and inducibility of P450 enzymes during liver ontogeny.
    Rich KJ; Boobis AR
    Microsc Res Tech; 1997 Dec; 39(5):424-35. PubMed ID: 9408909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New perspectives on the impact of cytochrome P450 3A expression for pediatric pharmacology.
    Stevens JC
    Drug Discov Today; 2006 May; 11(9-10):440-5. PubMed ID: 16635807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental expression of the major human hepatic CYP3A enzymes.
    Stevens JC; Hines RN; Gu C; Koukouritaki SB; Manro JR; Tandler PJ; Zaya MJ
    J Pharmacol Exp Ther; 2003 Nov; 307(2):573-82. PubMed ID: 12975492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes.
    Hines RN; McCarver DG
    J Pharmacol Exp Ther; 2002 Feb; 300(2):355-60. PubMed ID: 11805191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic Cytochrome P450 Activity, Abundance, and Expression Throughout Human Development.
    Sadler NC; Nandhikonda P; Webb-Robertson BJ; Ansong C; Anderson LN; Smith JN; Corley RA; Wright AT
    Drug Metab Dispos; 2016 Jul; 44(7):984-91. PubMed ID: 27084891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms.
    Pearce RE; Gotschall RR; Kearns GL; Leeder JS
    Drug Metab Dispos; 2001 Dec; 29(12):1548-54. PubMed ID: 11717173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive expression of cytochrome P450 in foetal and adult porcine livers-Effects of body weight.
    Rasmussen MK; Theil PK; Oksbjerg N
    Toxicol Lett; 2016 Sep; 258():87-92. PubMed ID: 27320961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil.
    Hyland R; Roe EG; Jones BC; Smith DA
    Br J Clin Pharmacol; 2001 Mar; 51(3):239-48. PubMed ID: 11298070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of hepatic drug-metabolizing cytochrome p450 enzymes and their intercorrelations: a meta-analysis.
    Achour B; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2014 Aug; 42(8):1349-56. PubMed ID: 24879845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.